Technique: Proximity Extension Assay (PEA) coupled with qPCR, readout NPX **.
Target Proteomics analysis for the identification of 92 specific proteins. Olink® Target 96 Oncology II features putative cancer-related human proteins that participate in biological mechanisms that are central to the initiation and progression of cancer, e.g. angiogenesis, cell-cell signaling, cell-cycle control, and inflammation.
